The novel non‐steroidal MR antagonist finerenone improves metabolic parameters in high‐fat diet‐fed mice and activates brown adipose tissue via AMPK‐ATGL pathwayVincenzo Marzolla, Massimiliano Caprio, Maria Rosa Ciriolo et al.|The FASEB Journal|2020Cited by 69